文献速递牙体牙髓病

Semaphorin 7A加速根尖周病变的炎性骨溶解

Semaphorin 7A Accelerates the Inflammatory Osteolysis of Periapical Lesions.
PubMed 文献 · J Endod · 2022-02-24

本研究探讨SEMA7A在根尖周病变炎性进展中的调控作用及机制。体外实验显示重组人/鼠SEMA7A可上调人牙周膜细胞炎性因子及基质金属蛋白酶表达;C57BL/6小鼠体内实验显示rSEMA7A加重牙槽骨骨溶解和免疫细胞浸润;AKT抑制剂LY294002可抑制SEMA7A的促炎作用。

要点

  • 重组人/鼠SEMA7A可上调人牙周膜细胞IL-1β、IL-18、COX-2、MMP-1和MMP-3的mRNA及蛋白水平。
  • 小鼠体内实验中,rSEMA7A治疗组较其他3组加重牙槽骨骨溶解并促进根尖区免疫细胞浸润。
  • AKT抑制剂LY294002可抑制SEMA7A的促炎作用,提示AKT信号通路部分介导该效应。

核心结论

  • SEMA7A可能加重现有根尖周病变的炎症反应和骨破坏。
  • SEMA7A在人牙周膜细胞中的促炎作用可能部分通过AKT信号转导通路介导。

研究设计与样本

  • 体外实验:从完整、无龋、健康的第三磨牙收集人牙周膜细胞,用重组人/鼠SEMA7A刺激,采用RT-qPCR、Western blot和ELISA检测。
  • 体内实验:20只C57BL/6小鼠随机分为4组:健康对照组、开髓组、开髓+生理盐水处理组、开髓+rSEMA7A处理组。
  • 在第0、7、14天分别于根尖周围颊黏膜注射20微升无菌生理盐水或4微克rSEMA7A,第21天收集下颌组织。
  • 采用微型计算机断层扫描和免疫组化染色鉴定根尖周区域骨破坏和炎性浸润。
  • 用AKT抑制剂LY294002预处理人牙周膜细胞后再予rSEMA7A刺激,以确定AKT信号激活的作用。

主要发现

  • rSEMA7A处理后,人牙周膜细胞中IL-1β、IL-18、环氧合酶-2、MMP-1和MMP-3的mRNA及蛋白水平显著上调。
  • 体内实验中,与其他3组相比,rSEMA7A治疗加重牙槽骨骨溶解并促进免疫细胞浸润至根尖区,同时IL-1β、IL-18、MMP-1和MMP-3表达水平升高。
  • 应用AKT抑制剂LY294002可抑制SEMA7A的促炎作用。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Semaphorin 7A (SEMA7A), the only class VII semaphorin member, has been considered as a potent immunomodulatory regulator whose function in periapical lesions remains unclear. In our previous study, we found that SEMA7A was up-regulated in human periapical periodontitis and might be involved in the immune response and tissue destruction of periapical lesions. In this research, we aimed to further explore the specifical regulatory role of SEMA7A as well as its regulatory mechanisms in the inflammatory progression of periapical lesions. METHODS: Human periodontal ligament cells (hPDLCs) were collected from intact, caries-free, and healthy third molars and stimulated with recombinant human/mouse SEMA7A (rSEMA7A). Real-time quantitative polymerase chain reaction (RT-qPCR), Western blot analysis, and enzyme-linked immunosorbent assay were used to detect the messenger RNA and protein levels of inflammatory cytokines and matrix metalloproteinases (MMPs) in hPDLCs. Twenty C57BL/6 mice were randomly divided into 4 groups: the healthy control group, pulp exposure group, pulp exposure and saline treatment group, and pulp exposure and rSEMA7A treatment group. Twenty microliters of sterile saline or 4 μg rSEMA7A were injected respectively into the buccal mucosa around the root apex at day 0, 7, and 14. Mandibular tissues were collected at day 21. Micro-computed tomographic and immunohistochemical staining were used to identify the bone destruction and inflammatory infiltration in periapical areas. Finally, an AKT inhibitor (LY294002) was used to pretreat hPDLCs before rSEMA7A stimulation to determine the role of AKT signaling activation in this process. RESULTS: After treatment with rSEMA7A, the messenger RNA and protein levels of interleukin (IL)-1β, IL-18, cyclooxygenase-2, MMP-1, and MMP-3 were remarkably up-regulated in hPDLCs. For in vivo experiments, compared with the other 3 groups, the treatment of rSEMA7A aggravated the osteolysis of alveolar bone and promoted the infiltration of immune cells into the apex area, along with increased expression levels of IL-1β, IL-18, MMP-1, and MMP-3. Furthermore, we found that the proinflammatory role of SEMA7A could be inhibited by the application of the AKT inhibitor (LY294002). CONCLUSIONS: SEMA7A likely aggravates the inflammatory reaction and bone destruction of existing periapical lesions. The proinflammatory role of SEMA7A in hPDLCs could partially be mediated through the AKT signaling transduction pathway.

来源:J Endod,查看原文。版权归原作者所有。

引用

  1. Wang L, Song Y, Yi X, et al. Semaphorin 7A Accelerates the Inflammatory Osteolysis of Periapical Lesions. J Endod. 2022. PMID: 35218761. doi:10.1016/j.joen.2022.01.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。